Zengxin Jiang et al. (2024) also reported a novel therapeutic strategy to prevent and treat postmenopausal osteoporosis by inhibiting the ferroptosis of osteocytes via the NRF2/Dnmt3a/RANKL axis. Here, TNFSF11 is linked to postmenopausal osteoporosis.